(Q40233356)

18 September 2017

title

Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma (English)

1 reference

18 September 2017

PeiHong Jiang

1

1 reference

18 September 2017

Hiroyuki Watanabe

2

1 reference

18 September 2017

Gensaku Okada

3

1 reference

18 September 2017

Koushiro Ohtsubo

4

1 reference

18 September 2017

Hisatsugu Mouri

5

1 reference

18 September 2017

Tomoya Tsuchiyama

6

1 reference

18 September 2017

Fan Yao

7

1 reference

18 September 2017

Norio Sawabu

8

1 reference

18 September 2017

publication date

5 September 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

97

1 reference

18 September 2017

issue

11

1 reference

18 September 2017

page(s)

1267-1273

1 reference

Cancer burden in the year 2000. The global picture

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Serum tumor markers and molecular biological diagnosis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Purification, molecular cloning, and expression of a novel growth-promoting factor for retinal pigment epithelial cells, REF-1/TFPI-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Hypermethylation of CpG islands in primary and metastatic human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00308.X

10.1111/J.1349-7006.2006.00308.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference